RenovoRx, Inc.
RNXT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,814 | -$10,232 | -$9,889 | -$6,324 |
| Dep. & Amort. | $0 | $0 | $6 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,174 | $1,078 | $0 | $147 |
| Change in WC | $280 | $605 | $428 | -$265 |
| Other Non-Cash | -$1,765 | -$1,709 | $644 | $517 |
| Operating Cash Flow | -$9,125 | -$10,258 | -$8,811 | -$5,916 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | $0 | $0 | -$15 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$8,000 | $0 |
| Inv. Sales/Matur. | $0 | $2,032 | $5,968 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | $2,032 | -$2,032 | -$15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,977 |
| Stock Issued | $15,016 | $5,000 | $42 | $14,563 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $102 | $8 | $0 | $2,788 |
| Financing Cash Flow | $15,118 | $5,008 | $42 | $19,328 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,981 | -$3,218 | -$10,801 | $13,397 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,173 | $4,391 | $15,192 | $1,795 |
| End Cash | $7,154 | $1,173 | $4,391 | $15,192 |
| Free Cash Flow | -$9,137 | -$10,258 | -$8,811 | -$5,931 |